Clinical Updates in Frontline CHL

A

Safety Data of Brentuximab Vedotin in cHL and Management of Adverse Reactions: A Focus on Peripheral Neuropathy

By Anna Sureda 4 Videos
489 views
August 30, 2022
1 Comment
Login to view comments. Click here to Login
23:24
SOHO Brazil 2023

2023 SOHO® Brazil: "How I Sequence New Agents in First and Seco…

Feat. A. Moskowitz
04:34
ecancer

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary M…

Feat. E. Zucca
06:28
PrecisCa

Updates From the ECHELON-1 Trial Utilizing Brentuximab in Hodgkin’s …

Feat. M. Kamdar
21:26
Hackensack Meridian John Theurer Cancer Center

A+AVD in Frontline cHL: Barriers and Challenges

Feat. T. Feldman
31:25
Indy Hematology Review

Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…

Feat. M. Lunning
10:04
Stephen M. Ansell

NCCN Guidelines for the Treatment of cHL: A New Standard of Care

15:23
EHA 2022 Conference Coverage

Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Clas…

Feat. J. Radford
40:13
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Feat. R. C. Lynch
27:15
Indy Hematology Review

Targeting and Treating Indolent Lymphomas and Hodgkin Lymphoma

Feat. N. Bartlett
41:20
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lym…

Feat. N. Bartlett
19:27
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Updates in Management of Hodgkin Lymphoma

Feat. J. Svoboda